Clinical Activity

Since June 2008, the G.B. Bietti Foundation for Study and Research in Ophthalmology ICCRS  has been providing inpatient services and treatment at the Ospedale Britannico Hospital, part of the San Giovanni Addolorata Hospital, with 4 beds and an additional 4 beds to be added imminently (D.G.R. n. 212 of 29/03/2008, D.P.C.A. n. U0027 of 16/06/2009).

As part of the activities chargeable to the National Health Service, every year the Foundation provides numerous treatment and advanced surgery services, thanks to the clinical and diagnostic experience of its physicians. In particular, most of the clinical and surgical activity is focused on glaucoma and diseases of the retina, crystalline lens, and cornea, with an emphasis on techniques and materials that are at the forefront of innovation in ophthalmology.

Ab-interno retinal surgery (vitrectomy) is performed with latest-generation instruments, with high cutting and aspiration capability, which allows for minimal intraocular invasiveness and reduced post-operation recovery times.

Corneal surgery is performed with the help of a latest-generation femtosecond laser. Full-thickness corneal transplants are performed along with lamellar, anterior, or posterior corneal transplants.

Glaucoma surgery is performed via filtration surgery (trabeculectomy) and the use of latest-generation drainage systems to control intraocular pressure.

The G.B. Bietti Foundation has established a Centre for Maculopathies at the Ospedale Britannico, which centre was inaugurated on 26 May 2010 in the presence of the Ministry of Health Ferruccio Fazio, the Undersecretary to the Presidency of the Council of Ministers Gianni Letta and the President of the Istituto Superiore di Sanità Enrico Garaci. The Centre, staffed by professional researchers working on diagnostics, treatment, and research in the field of macular degeneration related to age, myopia, and diabetes, also hosts clinical trials focusing on new treatments and new applications of existing treatment.

The IRCCS is endowed with the latest and most advanced technology for both the diagnosis and treatment of severe visual pathologies, including the following:

  • A latest-generation spectral domain OCT for the early diagnosis of macular degeneration, which makes it possible to perform a linear scan of the retina and obtain an image  of the retinal thickness from the vitreous humour to the choroid
  • A microperimeter for the functional study of the macula, which makes it possible to obtain digital colour retinal images in meiosis
  • Digital fluoroangiography for static and dynamic examinations
  • Latest-generation micropulse diode laser for the photocoagulation of diabetic retinopathy
  • A Confoscan Microscope for corneal endothelium examinations
  • HRT for the study of the posterior segment

With regards to medical treatment, the G.B. Bietti Foundation IRCCS uses innovative drugs such as Lucentis® (Ranibizumab) for age-related macular degeneration and Ozurdex® (dexamethasone intravitreal implant) to treat macular edema following branch or central retinal vein occlusion.

During 2010, the IRCCS acquired additional latest-generational technology, such as a femtosecond laser used for cornea transplants and the correction of irregular astigmatism.

Eye Bank